Annual report pursuant to Section 13 and 15(d)

Stock-Based Compensation - Stock options (Details)

v3.19.3.a.u2
Stock-Based Compensation - Stock options (Details) - USD ($)
12 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Stock Options    
Assumed in connection with license acquired- Ohr 106,000  
Granted 6,269,966  
Outstanding, Ending balance 6,375,966  
Exercisable 4,117,187  
Weighted Average Exercise Price per Share    
Assumed in connection with license acquired- Ohr $ 13.31  
Granted 2.52  
Outstanding, Ending balance 2.70  
Exercisable $ 1.23  
Weighted Average remaining contractual term (years) and Aggregate Intrinsic Value    
Outstanding 9 years 4 months 24 days 0 years
Exercisable 9 years 2 months 12 days  
Outstanding $ 16,650,319  
Exercisable $ 16,650,319